Your browser doesn't support javascript.
loading
Detectable Concentrations of Inhaled Tobramycin in Critically Ill Children Without Cystic Fibrosis: Should Routine Monitoring Be Recommended?
Miller, Jamie L; Lepa, Trisha M; Ranallo, Courtney; Chaaban, Hala; Skrepnek, Grant H; Johnson, Peter N.
  • Miller JL; Department of Pharmacy: Clinical and Administrative Science, University of Oklahoma College of Pharmacy, Oklahoma City, OK.
  • Lepa TM; Department of Pediatrics, University of Oklahoma College of Medicine, Oklahoma City, OK.
  • Ranallo C; Department of Pharmacy, Brooklyn Hospital Center, Brooklyn, NY.
  • Chaaban H; Department of Pediatrics, University of Oklahoma College of Medicine, Oklahoma City, OK.
  • Skrepnek GH; Department of Pediatrics, University of Oklahoma College of Medicine, Oklahoma City, OK.
  • Johnson PN; Department of Pharmacy: Clinical and Administrative Science, University of Oklahoma College of Pharmacy, Oklahoma City, OK.
Pediatr Crit Care Med ; 18(12): e615-e620, 2017 Dec.
Article en En | MEDLINE | ID: mdl-29206744

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tobramicina / Enfermedad Crítica / Antibacterianos Tipo de estudio: Diagnostic_studies / Observational_studies Límite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male / Newborn Idioma: En Año: 2017 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tobramicina / Enfermedad Crítica / Antibacterianos Tipo de estudio: Diagnostic_studies / Observational_studies Límite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male / Newborn Idioma: En Año: 2017 Tipo del documento: Article